Liabilities / Assets
68th percentile
Higher debt load relative to assets than 68% of similar nonprofits.
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.26x
Liabilities / Revenue
57th percentile
Higher debt load relative to revenue than 57% of similar nonprofits.
Net Margin
35th percentile
Higher net margin than 35% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
66th percentile
Faster asset growth than 66% of similar nonprofits.
Revenue Growth
32nd percentile
Faster revenue growth than 32% of similar nonprofits.
Balance Sheet
Assets
Up$3,069,785
Up $186,133 (+6.5%) from 2012
Net Assets
Up$2,263,497
Up $3,600 (+0.2%) from 2012
Liabilities
Up$806,288
Up $182,533 (+29%) from 2012
Revenue And Expenses
Revenue
$3,792,104
No earlier filing loaded for comparison.
Expenses
Down$3,792,434
Down $73,477 (-1.9%) from 2012
Net Income
-$330
No earlier filing loaded for comparison.
Historical Trend
Filing Detail Status
This 2013 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- May 1, 2012 to Apr 30, 2013
Mission and Program Overview
Mission
The argyle's primary purpose is to foster and support the texas biomedical research institute, a 501(c)(3) organization engaged in not-for-profit biomedical research to advance the health of the global community through innovative research in genetics, virology, and immunology.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2013 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $3,069,785
- Liabilities
- $806,288
- Net assets
- $2,263,497
- Revenue
- $3,792,104
- Expenses
- $3,792,434
- Net income
- -$330